-+ 0.00%
-+ 0.00%
-+ 0.00%

ZENTALIS PHARMACEUTICALS PROVIDES CORPORATE UPDATE AND HIGHLIGHTS KEY MILESTONES AND EXPECTED MOMENTUM IN THE AZENOSERTIB DEVELOPMENT PROGRAM FOR 2026

路透·01/06/2026 13:00:09

登录查看新闻详情